David A.

David A. is an accomplished leader in global medical affairs and business development within the oncology sector, currently serving as Head of Pipeline, BD & Hematology at Takeda Oncology since March 2021. With a strong background in cross-functional leadership, David has managed multiple myeloma and oncology portfolios, overseeing clinical and pre-clinical assets while also directing strategic initiatives and training programs. Prior experience includes roles at AbbVie and Pharmacyclics, where David led brand strategy and external collaborations. With a foundational background in research and a Doctorate in Biology from UC San Diego, as well as an MBA from Duke University, David has effectively combined scientific expertise with business acumen throughout a diverse career spanning several prestigious organizations.